Tivozanib kidney cancer drug. Close-up of a tub and capsules of the kidney cancer drug tivozanib, marketed under the name Fotivda. Tivozanib is an oral VEGF receptor tyrosine kinase inhibitor used for the treatment of first line (treatment naive) patients with renal cell carcinoma. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Marazzi, Dr. P. |
Bildgröße: | 5177 px × 3451 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: |
|